Liberty BioSecurity was a founder-funded, start-up biotechnology company that developed biologics with solid commercial use potential. The company lacked the business acumen to prioritize biologic development based on revenue potential and required additional funding to get the biologics market ready.
Director of Business Operations
I was accountable for the market research, analysis, business operations, AR&D prioritization, capital raise, full financials, budgeting, and defining job descriptions within each department. I served as the conduit between the scientists (AR&D) and business operations, working to create superior products and determine market viability. Due to my expertise, I was asked to build the entire business division and then led the process to develop a capital raise structure and strategy.
Developing a product in any novel biology program involves a complicated and lengthy process that can take years of AR&D, scientific testing and government trials before a product is approved and ready for market. My work in business operations, specifically, projecting revenues and TAM, provided viable value propositions for products in the pipeline, allowed Liberty BioSecurity to prioritize biologic development opportunities with a clear go-to-market strategy in place. The business capital raise structure I created helped secure a term sheet and development partnerships.